Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENDRA Life Sciences Inc

3.45
-0.2100-5.74%
Post-market: 3.28-0.1700-4.93%19:51 EDT
Volume:55.68K
Turnover:194.91K
Market Cap:2.55M
PE:-0.06
High:3.58
Open:3.50
Low:3.38
Close:3.66
Loading ...
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
May 31, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 02, 2024

Correspondence

Form CORRESP - Correspondence
Mar 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2023

Major Issues Report

Form 8-K - Current report